Trials / Completed
CompletedNCT00560885
AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation
AtriCure Synergy Bipolar RF Energy Lesions for Permanent Atrial Fibrillation Treatment During Concomitant On-Pump Endo/Epicardial Cardiac Surgery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- AtriCure, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
ABLATE is a prospective, non-randomized multi-center clinical trial to demonstrate the safety and effectiveness of the AtriCure Bipolar System for treating permanent atrial fibrillation during concomitant on-pump cardiac surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AtriCure Bipolar System | Surgical bipolar radiofrequency ablation using the AtriCure Bipolar System |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2009-12-01
- Completion
- 2012-12-01
- First posted
- 2007-11-20
- Last updated
- 2013-03-29
- Results posted
- 2013-03-14
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00560885. Inclusion in this directory is not an endorsement.